cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Revance Therapeutics Inc
6 own
9 watching
Current Price
$5.68
$0.19
(3.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
769.13M
52-Week High
52-Week High
37.98000
52-Week Low
52-Week Low
5.00000
Average Volume
Average Volume
1.29M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization769.13M
icon52-Week High37.98000
icon52-Week Low5.00000
iconAverage Volume1.29M
iconDividend Yield--
iconP/E Ratio--
What does the Revance Therapeutics Inc do?
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacturing, and commercialization of novel botulinum toxin products for various aesthetic and therapeutic indications. The company's lead drug candidate is DaxibotulinumtoxinA for injection (RT002), which is in Phase III clinical trials to treat glabellar (frown) lines, as well as in Phase II clinical trials for the treatment of cervical dystonia and plantar fasciitis. It is also developing DaxibotulinumtoxinA topical gel (RT001) that is in preclinical development. The company was formerly known as Essentia Biosystems, Inc. and changed its name to Revance Therapeutics, Inc. in April 2005. Revance Therapeutics, Inc. was founded in 1999 and is headquartered in Newark, California.
Read More
How much money does Revance Therapeutics Inc make?
News & Events about Revance Therapeutics Inc.
Ticker Report
8 months ago
Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC Get Rating) have earned an average rating of Moderate Buy from the twelve brokerages that are presently covering the firm, MarketBeat reports. Two analysts have rated the stock with a hold rating and three have given a buy ...
Zolmax
11 months ago
Revance Therapeutics, Inc. (NASDAQ:RVNC Get Rating) President Dustin S. Sjuts sold 21,508 shares of the companys stock in a transaction that occurred on Thursday, March 9th. The stock was sold at an average price of $31.59, for a total value of $679,437.72. Following the sale, the president now owns...
PR Newswire
12 months ago
Facial Injectable Global Market Report 2022: Sector to Reach $23.55 Billion by 2027 at a 15.46% CAGR Facial Injectable Global Market Report 2022: Sector to Reach $23.55 Billion by 2027 at a 15.46% CAGR PR Newswire DUBLIN, Feb. 28, 2023 DUBLIN, Feb. 28, 2023 /PRNewswire/ -- The 'Facial...
Business Wire
12 months ago
Revance Therapeutics, Inc. (RVNC), today announced that the company will participate in the 43rd Annual Cowen Healthcare Conference, taking place March 6-8, 2023, in Boston, Massachusetts. President, Dustin S. Sjuts, and Chief Financial Officer, Tobin Schilke, are scheduled to participate in a...
Business Wire
1 year ago
Revance Therapeutics, Inc. (RVNC) today announced that new data on DAXXIFY will be presented at the annual meeting of Association of Academic Physiatrists (AAP), taking place in Anaheim, California, February 21-24, 2023. The supplemental biologics license agreement for DAXXIFY for the treatment of...
Frequently Asked Questions
Frequently Asked Questions
What is Revance Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Revance Therapeutics Inc shares?
plus_minus_icon
How can I buy Revance Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Revance Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Revance Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Revance Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Revance Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Revance Therapeutics Inc?
plus_minus_icon
What percentage is Revance Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Revance Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.68
$0.19
(3.46%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00